treatment updated for her2 positive breast cancer: changing paradigms
Published 3 years ago • 2.9K plays • Length 30:57Download video MP4
Download video MP3
Similar videos
-
2:43
sequencing treatment options in her2 positive breast cancer: 2023 best of breast conference
-
0:55
neoadjuvant treatment approach for her2 positive breast cancer
-
5:45
her2-positive breast cancer: a paradigm shift in diagnosis and therapy
-
4:12
clinical implications of ‘low’ her2 expression: 2023 best of breast conference
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
0:58
treatment approach for metastatic her2 positive breast cancer
-
2:02
asco22 metastatic breast cancer updates | lee schwartzberg, md | renown institute for cancer
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
25:20
her2 low breast cancer a new therapeutic subtype | 2023 ku breast cancer year in review conference
-
1:34
dr. mehta on the current treatment paradigm in her2-positive gastric cancer
-
52:21
new & supporting data for optimizing therapy in her2 breast cancer | dr. irene and dr. vogel
-
56:42
research update for her2-positive mbc | 2021-2022 embrace mbc virtual forum series
-
1:54
updates in treatments for her2-positive gea
-
41:53
guideline updates for extended endocrine therapy decision-making in hr , early-stage breast cancer
-
1:10:36
updates in extended endocrine therapy for hr breast cancer | asco21 & national practice guidelines
-
2:43
margetuximab for the treatment of her2-positive breast cancer
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan